OptiTROP-Lung03 Evaluates Sacituzumab Tirumotecan in EGFR-Mutated NSCLC
FDA Grants Accelerated Approval of Sunvozertinib for Metastatic EGFR-Positive NSCLC
AGEAN: Analysis Explores Impact of Post-Surgical MRD Status in NSCLC
Study Investigates Targeted Interventions to Improve Lung Cancer Screening Uptake in High-Risk Patients
HERTHENA-Lung02 Evaluates Patritumab Deruxtecan in EGFR-Mutated NSCLC
DART Trial Assesses Relationship Between ctDNA and Outcomes in Unresectable NSCLC